skip to Main Content

SPEAKERS

SAMPLE OF KEYNOTE SPEAKERS AND THEIR CASE STUDIES

CASE STUDY / DAY 1

Improving Recruitment and Retention by Targeted Patient Engagement Strategies

Actionable and sustainable solutions for improving clinical trial recruitment and retention should address participant and other stakeholders’ barriers, and center on better communication and collaboration among participants, investigators, referring providers and clinical trial sites.

  • Clinical trial recruitment and retention, particularly for underrepresented groups, is a continuing challenge.
  • Key participant barriers include mistrust, lack of comfort with the process, lack of awareness, and logistical (time and resource) constraints.
  • A multi-stakeholder approach centered on improved communication and collaboration is key to developing actionable and sustainable solutions
  • Utilizing tools to target underrepresented groups may increase enrollment and retention

Luther
T. CLARK, MD

Deputy Chief Patient Officer

Merck

Melanie
GOODWIN

Director, Patient Recruitment Programs

Pfizer

CASE STUDY / DAY 1

Increasing Patient Awareness of Clinical Trials – How Do We Effectively Increase that Awareness for Patient and Their Influencers?

This presentation will address how we develop a picture of the “typical” patient to inform study teams about their challenges and motivators to recruitment, what information they need to support their decision to participate and where they will look for that information. We will further demonstrate a case example of how using this helps us increase awareness, and in turn, increase enrollment.

  • Building the picture of the “typical” patient
  • Establish awareness needs and communication pathways
  • Understand key influencers and their awareness needs
  • Demonstrate how this process positively impacts trial enrollment

This year Summit will host speakers from the world’s leading companies.
See sample of key note speakers.

Jane
FANG, M.D., M.S.

MedImmune R&D Information Head for Clinical Biologics

AstraZeneca

Melanie
GOODWIN

Director, Patient Recruitment Programs

Pfizer

Luther
T. CLARK, MD

Deputy Chief Patient Officer

Merck

Aniket
JOSHI

Associate Director, R&D Innovation

Otsuka

Fatima
SCIPIONE

Senior Director, Patient Advocacy

Takeda

Michelle
CROUTHAMEL

Digital Platform Leader

GSK

CASE STUDY / DAY 2

Reimagining Patient Recruitment

The competition for right clinical trial participants is at an all-time high, especially true for precision medicine driven trials involving oncology and rare diseases. Trial recruitment has to go beyond traditional site centric approach that relies on obsolete site questionnaires. Patient-centric recruitment approach empowered by advances data analytics of real world evidence data and trial intelligence information will provide deep insights of targeted patient population and treatment pathway for precision recruitment. This new way of patient recruitment is also calling for new service capability in industry to bridge the worlds of healthcare providers and biopharma companies.

  • Current competitive trial landscape to drive paradigm shift of patient recruitment
  • Patient-centric recruitment approach
  • Advanced data science and analytics’ role in patient-centric recruitment
  • Call for new service capability to bridge the worlds of healthcare providers and biopharma companies

Jane
FANG M.D., M.S.

MedImmune R&D Information Head for Clinical Biologics

AstraZeneca

FOR MORE INFORMATION REQUEST FULL PROGRAMME

See what keynote speakers will be taking part in the exclusive speaking panel.
Explore what Case Studies will be discussed by our senior corporate speakers

7th Annual Patient Recruitment and Retention America Summit will start in
TIME IS RUNNING OUT! DON’T RISK MISSING IT
Back To Top